EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluorine‐18‐Labeled Nucleotide Analogs Targeting Ecto‐5'‐Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors

Clemens Dobelmann, Constanze C Schmies, Georg Wilhelm Rolshoven, Mirko Scortichini, Stefan Wagner, Andreas Isaak, Riham M Idris, Jennifer Dabel, Lucie Grey, Karolina Losenkova, Susanne Moschütz, Haneen Al Hroub und 12 weitere

Angewandte Chemie International Edition · 20.04.2026 · 65 (17)

DOI: 10.1002/anie.202522758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 15.03.2026. Verfasst von Clemens Dobelmann und 23 weiteren Autor:innen. Beteiligte Einrichtung: European Institute for Molecular Imaging (EIMI), University of Muenster, Münster, Germany. Hauptthemen laut MEDLINE: Positron-Emission Tomography, 5'-Nucleotidase, Fluorine Radioisotopes, Nucleotides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, German Research Foundation, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ecto‐5’‐nucleotidase (CD73) is a potential new drug target for cancer immunotherapy. Its overexpression is associated with various aggressive cancers, including triple‐negative breast cancer (TNBC) and pancreatic cancer, making it a promising target for diagnostic imaging. Besides antibodies, small‐molecule CD73 inhibitors have been developed and are currently in clinical trials. This study aimed to develop and evaluate fluorine‐18 labeled high‐affinity CD73 inhibitors as tracers for the non‐invasive positron emission tomography (PET) imaging of CD73 expression in cancer. Two CD73 inhibitors were selected for radiolabeling based on their high potency (K i values of ca. 1 nM) and favorable pharmacokinetic properties, yielding [ 18 F]PSB‐19427 ([ 18 F] 1 ) and [ 18 F]MRS‐4648 ([ 18 F] 2 ). Ex vivo imaging studies on human breast cancer tissues indicated specific binding of both radiotracers. Subsequent in vivo studies proved [ 18 F] 1 to be superior due to its long elimination half‐life and its accumulation in TNBC and pancreatic cancer tissues, suggesting its potential as a versatile PET tracer for imaging of various solid tumors. Compared to [ 18 F]FDG, [ 18 F] 1 was superior in visualizing TNBC, offering potential advantages over [ 18 F]FDG in terms of specificity and diagnostic accuracy. Thus, [ 18 F] 1 is a PET tracer with outstanding properties suitable for broad application in cancer diagnosis and personalized medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission Tomography5'-NucleotidaseFluorine RadioisotopesNucleotidesRadiopharmaceuticalsHumansAnimalsFemaleMice

Substanzen

5'-NucleotidaseFluorine RadioisotopesFluorine-18NucleotidesRadiopharmaceuticals

Autor:innen und Institutionen

  • European Institute for Molecular Imaging (EIMI), University of Muenster, Münster, Germany.
  • PharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry University of Bonn, Bonn, Germany.
  • Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Nuclear Medicine, University Hospital Muenster, Münster, Germany.
  • Institut Für Pharmazeutische und Medizinische Chemie, University of Muenster, Muenster, Germany.
  • Medicity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.

ORCID-Profile: Anna Junker

Förderung

  • Intramural NIH HHS
  • German Research Foundation
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Dobelmann, C., Schmies, C. C., Rolshoven, G. W., Scortichini, M., Wagner, S., Isaak, A., Idris, R. M., Dabel, J., Grey, L., Losenkova, K., Moschütz, S., Hroub, H. A., Keim, A., Höppner, S., Sandholm, J., Boström, P., Hollmén, M., Sträter, N., Hermann, S., …, & Junker, A. (2026). Fluorine‐18‐Labeled Nucleotide Analogs Targeting Ecto‐5'‐Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors. Angewandte Chemie International Edition, 65(17). https://doi.org/10.1002/anie.202522758

Vancouver

Dobelmann C, Schmies CC, Rolshoven GW, Scortichini M, Wagner S, Isaak A, et al. Fluorine‐18‐Labeled Nucleotide Analogs Targeting Ecto‐5'‐Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors. Angewandte Chemie International Edition. 2026;65(17). doi:10.1002/anie.202522758

BibTeX
@article{Dobelmann2026,
  author = {Dobelmann, Clemens and Schmies, Constanze C and Rolshoven, Georg Wilhelm and Scortichini, Mirko and Wagner, Stefan and Isaak, Andreas and Idris, Riham M and Dabel, Jennifer and Grey, Lucie and Losenkova, Karolina and Moschütz, Susanne and Hroub, Haneen Al and Keim, Antje and Höppner, Sandra and Sandholm, Jouko and Boström, Pia and Hollmén, Maija and Sträter, Norbert and Hermann, Sven and Yegutkin, Gennady G and Jacobson, Kenneth A and Schelhaas, Sonja and Müller, Christa E and Junker, Anna},
  title = {Fluorine‐18‐Labeled Nucleotide Analogs Targeting Ecto‐5'‐Nucleotidase (CD73) for Positron Emission Tomography Imaging of Solid Tumors},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {17},
  doi = {10.1002/anie.202522758}
}
Kostenlos starten →